Clinical Trial

hUC-MSC-Exosomes for T2DM - Safety & Efficacy

Name: hUC-MSC-Exosomes for T2DM - Safety & Efficacy — clinical trial record (NCT07693036)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HOPE-T2DM

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to Evaluate the Safety and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Adult Type 2 Diabetes Mellitus.

Trial Details

NCT Number	NCT07693036
Lead Sponsor	Peking University First Hospital Collaborators: ECHO Biotech
Conditions	Type 2 Diabetes Mellitus (T2DM)
Enrollment	66 participants
Start Date	2026-06-05
Primary Completion	2028-06-04 (estimated)
Study Completion	2028-06-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-09